1eah
From Proteopedia
(Difference between revisions)
m (Protected "1eah" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:1eah.png|left|200px]] | ||
| - | |||
{{STRUCTURE_1eah| PDB=1eah | SCENE= }} | {{STRUCTURE_1eah| PDB=1eah | SCENE= }} | ||
| - | |||
===PV2L COMPLEXED WITH ANTIVIRAL AGENT SCH48973=== | ===PV2L COMPLEXED WITH ANTIVIRAL AGENT SCH48973=== | ||
| - | |||
{{ABSTRACT_PUBMED_9261087}} | {{ABSTRACT_PUBMED_9261087}} | ||
Revision as of 11:13, 11 March 2013
Contents |
PV2L COMPLEXED WITH ANTIVIRAL AGENT SCH48973
Template:ABSTRACT PUBMED 9261087
About this Structure
1eah is a 4 chain structure with sequence from Human poliovirus 2. Full crystallographic information is available from OCA.
See Also
Reference
- Lentz KN, Smith AD, Geisler SC, Cox S, Buontempo P, Skelton A, DeMartino J, Rozhon E, Schwartz J, Girijavallabhan V, O'Connell J, Arnold E. Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes. Structure. 1997 Jul 15;5(7):961-78. PMID:9261087
- Shulman LM, Sofer D, Manor Y, Mendelson E, Balanant J, Salvati AL, Delpeyroux F, Fiore L. Antiviral activity of 3(2H)- and 6-chloro-3(2H)-isoflavenes against highly diverged, neurovirulent vaccine-derived, type2 poliovirus sewage isolates. PLoS One. 2011;6(5):e18360. Epub 2011 May 25. PMID:21904594 doi:10.1371/journal.pone.0018360
